about
Tissue factor and its natural inhibitor in pre-eclampsia and SGAParvovirus B19 infection in human pregnancySurfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancyThe fetal cardiovascular response to increased placental vascular impedance to flow determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis.Fetal cardiac ventricular volume, cardiac output, and ejection fraction determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysisMetabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.Detection of a microbial biofilm in intraamniotic infectionProteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry.Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection.Total hemoglobin concentration in amniotic fluid is increased in intraamniotic infection/inflammation.Mitochondrial manganese superoxide dismutase mRNA expression in human chorioamniotic membranes and its association with labor, inflammation, and infection.A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranesPatients with an asymptomatic short cervix (<or=15 mm) have a high rate of subclinical intraamniotic inflammation: implications for patient counselingIdentification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.Clinical significance of early (< 20 weeks) vs. late (20-24 weeks) detection of sonographic short cervix in asymptomatic women in the mid-trimester.Fragment Bb: evidence for activation of the alternative pathway of the complement system in pregnant women with acute pyelonephritis.Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations.Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses.Retinol binding protein 4--a novel association with early-onset preeclampsia.Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation.A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluidMaternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation.An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloimmunization: implications for the understanding of the fetal inflammatory response syndrome.Maternal plasma retinol binding protein 4 in acute pyelonephritis during pregnancy.Four-chamber view and 'swing technique' (FAST) echo: a novel and simple algorithm to visualize standard fetal echocardiographic planesSimple targeted arterial rendering (STAR) technique: a novel and simple method to visualize the fetal cardiac outflow tracts.Circulating angiogenic and antiangiogenic factors in women with eclampsia.Current debate on the use of antibiotic prophylaxis for caesarean section.Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age.Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.Varicella-zoster virus (chickenpox) infection in pregnancyPremature labor: a state of platelet activation?Amniotic fluid fetal hemoglobin in normal pregnancies and pregnancies complicated with preterm labor or prelabor rupture of membranes.Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturitionMaternal serum adiponectin multimers in preeclampsia.A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation.
P50
Q24323351-7249C9E5-DE97-4AA4-8E57-2F9E8A994529Q24594590-C210242C-8EB1-462D-8CA3-2EFC02AA4528Q24630219-3ED55A6D-14AE-4856-BA22-A59EE38975A9Q30436028-57708BF5-4502-48D7-95A5-837EA8544DA7Q30466036-B734D9AA-0568-41D7-BD9E-59477D3A192CQ30524877-7FBFAA53-3DF5-4283-9A5F-D2597A3A40B6Q33312883-66B44186-66C6-4DD1-AC91-C344D7E269F0Q33384672-C940122F-AC2E-4190-9C46-554409A84C5AQ33575629-11A93E12-1F10-4899-B56B-EB9AA5E10E0DQ33576316-D3D64F9A-27F1-49C1-973A-C146305957B2Q33660453-F805DBFD-9581-4968-82A5-3EBA5641C55DQ33921037-1EF3944D-3CD7-4407-98A6-300C052BE33AQ34011041-1DB0D0A1-593D-4AD3-9EBE-AB4CCF197DA1Q34080320-1C17B9BA-7C88-4ACF-A79E-97F8D5061198Q34114194-716867A9-2FCE-40F4-80D7-542570FEDCE0Q34118250-02AF34B1-780A-4B96-9997-42E11884CEFFQ34139940-4D79F6FA-6182-4DD8-9CB2-76F7C5731023Q34151967-E1018D8A-56B2-4D91-B802-A88DB3DA2AE8Q34234655-2C42D390-5439-4F06-98C3-2A8AFAEF30D2Q34234671-F2E5D75C-CB5B-4D2F-83F7-84D419C90C53Q34235212-3E7CCF2D-9FAE-4C02-8A8C-AF63B12C75E3Q34340129-C645E93C-6093-4867-8AE9-A2401B8CC46FQ34470845-9D1C684C-6C86-4187-B66C-E39E63400CB3Q34494722-02EE0053-40E0-40EB-9897-B6AA6C685BF6Q34505066-2450F172-655E-4750-A919-B8D3E5BDE011Q34505090-9D9732EC-9F33-4089-8E97-C739EA8268FBQ34553502-67A39CB7-8D37-4AAA-8A5F-9483659D8009Q34553772-E374B074-8CB3-4064-9C10-B2F810E2DF6FQ34567649-57043A68-E254-4A70-B833-BD860FC9DC93Q34567698-70229ABE-37B1-4F91-9392-9CF0D9284CEEQ34670638-8F2EFD21-AEBE-41C5-B521-A35BB56FE73CQ34685516-5DF5F0E7-042F-4640-B058-EE78663A6960Q35015398-0D59306E-D702-49B7-86D3-6D2F65EF838CQ35015402-68FDE487-535B-4022-80F4-DDC928C56603Q35162932-9159DD49-8659-443B-B8D9-E771B78EDAB0Q35185510-AAA4E7B7-F376-4B76-A7DB-CEA35EA6FA69Q35186751-467C0DA3-872D-469B-BC22-C5DE2D77CE77Q35186914-415EE0FA-090A-42E0-9E4E-1AA8FF10F975Q35194054-CCE656C2-2833-43FD-8744-0A578EE4AFF4Q35205183-D76AC046-C489-48C7-B615-0EB54C2B8475
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Edi Vaisbuch
@ast
Edi Vaisbuch
@en
Edi Vaisbuch
@es
Edi Vaisbuch
@nl
Edi Vaisbuch
@sl
type
label
Edi Vaisbuch
@ast
Edi Vaisbuch
@en
Edi Vaisbuch
@es
Edi Vaisbuch
@nl
Edi Vaisbuch
@sl
prefLabel
Edi Vaisbuch
@ast
Edi Vaisbuch
@en
Edi Vaisbuch
@es
Edi Vaisbuch
@nl
Edi Vaisbuch
@sl
P106
P1153
35293992100
P21
P31
P496
0000-0002-8400-9031
P569
2000-01-01T00:00:00Z